Full Text View
Tabular View
Study Results
Related Studies
Genotropin Study Assessing Use of Injection Pen
This study has been completed.
Study NCT00965484   Information provided by Pfizer

First Received on August 21, 2009.   Last Updated on January 26, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Growth Hormone Deficiency
Idiopathic Short Stature
Additional conditions recognized in this trial
Dwarfism
Dwarfism, Pituitary
Endocrine System Diseases
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Genetic Diseases, Inborn
Hypopituitarism
Hypothalamic Diseases
Musculoskeletal Diseases
Nervous System Diseases
Pituitary Diseases
Interventions listed in this trial
New Genotropin Pen
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services